Novartis Acquires Arctos Medical, Expanding Optogenetics Portfolio to Bring Gene Therapies to Patients with Severe Vision Loss
September 21 2021
Novartis today announced that it has acquired Arctos Medical, adding a pre-clinical optogenetics-based AAV gene […]